Katherine M. Moore, M.D.

  1. Psychiatrist

出版物

  1. Gardea-Resendez M, Winham SJ, Romo-Nava F, Cuellar-Barboza A, Clark MM, Andreazza AC, Cabello-Arreola A, Veldic M, Bond DJ, Singh B, Prieto ML, Nunez NA, Betcher H, Moore KM, Blom T, Colby C, Pendegraft RS, Kelpin SS, Ozerdem A, Miola A, De Filippis E, Biernacka JM, McElroy SL, Frye MA. Quantification of diet quality utilizing the rapid eating assessment for participants-shortened version in bipolar disorder: Implications for prospective depression and cardiometabolic studies. J Affect Disord. 2022 Aug 1; 310:150-155 Epub 2022 May 08
    View PubMed
  2. Nunez NA, Coombes BJ, Romo-Nava F, Bond DJ, Vande Voort J, Croarkin PE, Leibman N, Gardea Resendez M, Veldic M, Betcher H, Singh B, Colby C, Cuellar-Barboza A, Prieto M, Moore KM, Ozerdem A, McElroy SL, Frye MA, Biernacka JM. Clinical and Genetic Correlates of Bipolar Disorder With Childhood-Onset Attention Deficit Disorder. Front Psychiatry. 2022; 13:884217 Epub 2022 Apr 14
    View PubMed
  3. Gentry MT, Puspitasari AJ, McKean AJ, Williams MD, Breitinger S, Geske JR, Clark MM, Moore KM, Frye MA, Hilty DM. Clinician Satisfaction with Rapid Adoption and Implementation of Telehealth Services During the COVID-19 Pandemic. Telemed J E Health. 2021 Dec; 27 (12):1385-1392 Epub 2021 Feb 19
    View PubMed
  4. Pahwa M, Joseph B, Nunez NA, Jenkins GD, Colby CL, Kashani KB, Marin Veldic Veldic, Marin Veldic Veldic, Moore KM, Betcher HK, Ozerdem A, Cuellar-Barboza AB, McElroy SL, Biernacka JM, Frye MA, Singh B. Long-term lithium therapy and risk of chronic kidney disease in bipolar disorder: A historical cohort study. Bipolar Disord. 2021 Nov; 23 (7):715-723 Epub 2021 Mar 11
    View PubMed
  5. Nunez NA, Sola C, Kung S, Singh B, Ozerdem A, Veldic M, Croarkin PE, Moore KM, Betcher HK, Vande JL, Geske JR, Biernacka JM, Rummans TA, Bahn RS, Frye MA. Deiodinase variation and liothyronine treatment interaction to accelerate ECT response in major depression: Pilot data and implications for thyroid pharmacogenomic testing in mood disorders Personalized Medicine in Psychiatry. 2021; 29-30.
  6. Puspitasari AJ, Heredia D, Weber E, Betcher HK, Coombes BJ, Brodrick EM, Skinner SM, Tomlinson AL, Salik SS, Allen SV, O'Grady JS, Johnson EK, L'amoureux TM, Moore KM. Perinatal Mood and Anxiety Disorder Management in Multicenter Community Practices: Clinicians' Training, Current Practices and Perceived Strategies to Improve Future Implementation. J Prim Care Community Health. 2021 Jan-Dec; 12:2150132721996888
    View PubMed
  7. Cuellar-Barboza AB, McElroy SL, Veldic M, Singh B, Kung S, Romo-Nava F, Nunez NA, Cabello-Arreola A, Coombes BJ, Prieto M, Betcher HK, Moore KM, Winham SJ, Biernacka JM, Frye MA. Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selection. Int J Bipolar Disord. 2020 Jul 4; 8 (1):23 Epub 2020 July 04
    View PubMed
  8. Nunez NA, Singh B, Romo-Nava F, Joseph B, Veldic M, Cuellar-Barboza A, Cabello Arreola A, Vande Voort JL, Croarkin P, Moore KM, Biernacka J, McElroy SL, Frye MA. Efficacy and tolerability of adjunctive modafinil/armodafinil in bipolar depression: A meta-analysis of randomized controlled trials. Bipolar Disord. 2020 Mar; 22 (2):109-120 Epub 2020 Jan 07
    View PubMed
  9. Jahani Kondori M, Kolla BP, Moore KM, Mansukhani MP. Management of Restless Legs Syndrome in Pregnancy and Lactation. J Prim Care Community Health. 2020 Jan-Dec; 11:2150132720905950
    View PubMed
  10. Veldic M, Ahmed AT, Blacker CJ, Geske JR, Biernacka JM, Borreggine KL, Moore KM, Prieto ML, Vande Voort JL, Croarkin PE, Hoberg AA, Kung S, Alarcon RD, Keeth N, Singh B, Bobo WV, Frye MA. Cytochrome P450 2C19 Poor Metabolizer Phenotype in Treatment Resistant Depression: Treatment and Diagnostic Implications. Front Pharmacol. 2019; 10:83 Epub 2019 Feb 19
    View PubMed
  11. Campolong K, Jenkins S, Clark MM, Borowski K, Nelson N, Moore KM, Bobo WV. The association of exercise during pregnancy with trimester-specific and postpartum quality of life and depressive symptoms in a cohort of healthy pregnant women. Arch Womens Ment Health. 2018 Apr; 21 (2):215-224 Epub 2017 Oct 24
    View PubMed
  12. Leung JG, Kooda KJ, Frazee EN, Nelson S, Moore KM. Paliperidone Palmitate Associated with Necrotizing Deep Tissue Infection and Sepsis Requiring Surgical Intervention. Case Rep Psychiatry. 2015; 2015:364325 Epub 2015 Dec 30
    View PubMed
  13. Epstein RA, Moore KM, Bobo WV. Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges. Drug Healthc Patient Saf. 2015; 7:7-29 Epub 2014 Dec 24
    View PubMed
  14. Kelliny M, Croarkin PE, Moore KM, Bobo WV. Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literature. Ther Clin Risk Manag. 2015; 11:1193-212 Epub 2015 Aug 12
    View PubMed
  15. Frye MA, Prieto ML, Bobo WV, Kung S, Veldic M, Alarcon RD, Moore KM, Choi DS, Biernacka JM, Tye SJ. Current landscape, unmet needs, and future directions for treatment of bipolar depression. J Affect Disord. 2014 Dec; 169 Suppl 1:S17-23
    View PubMed
  16. Epstein RA, Moore KM, Bobo WV. Treatment of nonpsychotic major depression during pregnancy: patient safety and challenges. Drug Healthc Patient Saf. 2014; 6:109-29 Epub 2014 Sept 18
    View PubMed
  17. Rundell JR, Staab JP, Shinozaki G, Saad-Pendergrass D, Moore K, McAlpine D, Mrazek D. Pharmacogenomic testing in a tertiary care outpatient psychosomatic medicine practice. Psychosomatics. 2011 Mar-Apr; 52(2):141-6.
    View PubMed
  18. Wichman CL, Moore KM, Lang TR, St Sauver JL, Heise RH Jr, Watson WJ. Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy. Mayo Clin Proc. 2009; 84 (1):23-7
    View PubMed
  19. Rasmussen KG, Perry CL, Sutor B, Moore KM. ECT in patients with intracranial masses. J Neuropsychiatry Clin Neurosci. 2007 Spring; 19(2):191-3.
    View PubMed
  20. Larsen KE, Schwartz SA, Whiteside SP, Khandker M, Moore KM, Abramowitz JS. Thought control strategies used by parents reporting postpartum obsessions. Journal of Cognitive Psychotherapy. 2006 Win; 20(4):435-45.
  21. Netzel PJ, Sampson SM, Lapid MI, Moore KM, Rummans TA. Depression and anxiety in cancer patients: A focus on breast and gynecologic cancer. Women's Health in Psychiatry. 2006 Sept; 2(3):7-14.
  22. Netzel PJ, Sampson SM, Lapid MI, Moore KM, Rummans TA. Depression and anxiety in cancer patients: A focus on breast and gynecologic cancer. Women's Health in Primary Care. 2006 Sept; 9(8):16-32.
  23. Moore KM. Commentary on: Research Report: Anxiety Impacts Physical Disorders. Women's Health in Primary Care. 2006; 10(1):53-54.
  24. Moore KM, Lapid MI, Sampson SM, Netzel PJ, Lentz KB, Rummans TA. Depression in women: A life cycle perspective. Women's Health in Primary Care. 2005 Sep; 8:366-78.
  25. Moore KM, Lapid MI, Sampson SM, Netzel PJ, Rummans TA. Depression in women: diagnosis and treatment. Women's Health in Psychiatry. 2005; 1(1):6-14.
  26. Sampson SM, Lapid MI, Moore KM, Netzel PJ, Rummans TA. Depression in women with heart disease. Women's Health in Primary Care. 2005; 8(10):476-89.
  27. Abramowitz JS, Schwartz SA, Moore KM. Obsessional thoughts in postpartum females and their partners: content, severity, and relationship with depression. J Clin Psychol Med Settings. 2003 Sep; 10(3):157-64.
  28. Abramowitz JS, Schwartz SA, Moore KM, Luenzmann KR. Obsessive-compulsive symptoms in pregnancy and the puerperium: a review of the literature. J Anxiety Disord. 2003; 17 (4):461-78
    View PubMed
  29. Abramowitz J, Moore K, Carmin C, Wiegartz PS, Purdon C. Acute onset of obsessive-compulsive disorder in males following childbirth. Psychosomatics. 2001 Sep-Oct; 42 (5):429-31
    View PubMed
PST-20220146